Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 706 AL 720

Parkinson disease, substantia nigra vulnerability, and calbindin expression: Enlightening the darkness?

Blesa J, Vila M.

Mov Disord. 2019 Feb;34(2):161-163. doi: 10.1002/mds.27618. Epub 2019 Jan 24.

A Man Made Manic: Levodopa-Carbidopa-Induced Mania in Traumatic Brain Injury

Sablaban IM, Sivananthan M.

Prim Care Companion CNS Disord. 2019 Jan 17;21(1):18br02379. doi: 10.4088/PCC.18br02379.

Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms

Kanthasamy A, Jin H, Charli A, Vellareddy A, Kanthasamy A.

Pharmacol Ther. 2019 May;197:61-82. doi: 10.1016/j.pharmthera.2019.01.001. Epub 2019 Jan 22.

Coordination in adults with neurological impairment - A systematic review of uncontrolled manifold studies

Vaz DV, Pinto VA, Junior RRS, Mattos DJS, Mitra S.

Gait Posture. 2019 Mar;69:66-78. doi: 10.1016/j.gaitpost.2019.01.003. Epub 2019 Jan 2.

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders

Dhiman P, Malik N, Sobarzo-Sánchez E, Uriarte E, Khatkar A.

Molecules. 2019 Jan 24;24(3):418. doi: 10.3390/molecules24030418.

Pharmacological Management of Dementia with Lewy Bodies

Hershey LA, Coleman-Jackson R.

Drugs Aging. 2019 Apr;36(4):309-319. doi: 10.1007/s40266-018-00636-7.

Are we listening to everything the PARK genes are telling us?

Benson DL, Huntley GW.

J Comp Neurol. 2019 May 15;527(9):1527-1540. doi: 10.1002/cne.24642. Epub 2019 Feb 8.

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P.

Eur J Neurol. 2019 Jul;26(7):953-960. doi: 10.1111/ene.13914. Epub 2019 Mar 25.

Antagonist muscle activity during reactive balance responses is elevated in Parkinson's disease and in balance impairment

Lang KC, Hackney ME, Ting LH, McKay JL.

PLoS One. 2019 Jan 25;14(1):e0211137. doi: 10.1371/journal.pone.0211137. eCollection 2019.

A perilous path: the inborn errors of sphingolipid metabolism

Dunn TM, Tifft CJ, Proia RL.

J Lipid Res. 2019 Mar;60(3):475-483. doi: 10.1194/jlr.S091827. Epub 2019 Jan 25.

DaTQUANT: The Future of Diagnosing Parkinson Disease

Brogley JE.

J Nucl Med Technol. 2019 Mar;47(1):21-26. doi: 10.2967/jnmt.118.222349. Epub 2019 Jan 25.

Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease

Gruber D, Calmbach L, Kühn AA, Krause P, Kopp UA, Schneider GH, Kupsch A.

J Neural Transm (Vienna). 2019 Mar;126(3):309-318. doi: 10.1007/s00702-019-01972-7. Epub 2019 Jan 25.

Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death

Jakaria M, Haque ME, Cho DY, Azam S, Kim IS, Choi DK.

Mol Neurobiol. 2019 Aug;56(8):5799-5814. doi: 10.1007/s12035-019-1487-4. Epub 2019 Jan 25.

New windows into the brain: Central nervous system-derived extracellular vesicles in blood

Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J.

Prog Neurobiol. 2019 Apr;175:96-106. doi: 10.1016/j.pneurobio.2019.01.005. Epub 2019 Jan 25.

Radiotracers for imaging of Parkinson's disease

Abbasi Gharibkandi N, Hosseinimehr SJ.

Eur J Med Chem. 2019 Mar 15;166:75-89. doi: 10.1016/j.ejmech.2019.01.029. Epub 2019 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias